共 50 条
- [21] Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (05): : 469 - 472